← back to search

Phillip D. Toth

Midwest Eye Institute ·
Area of research
Surgery · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Lipoproteins and Cardiovascular Health, Hemodynamic Monitoring and Therapy, Blood Pressure and Hypertension Studies, and Diabetes, Cardiovascular Risks, and Lipoproteins.
h-index
15
citations
3,429
works
41
NIH funding
primary concept
Medicine
email

Recent publications

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity
JAMA 2023cited by 657position: middledoi
A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
New England Journal of Medicine 2014cited by 709position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2014–2014)Michael J. Koren · National Health and Medical Research Council1 papers (2014–2014)Lesley Burgess · Clinical Trial Investigators1 papers (2014–2014)Kate Tsirtsonis · Amgen (United States)1 papers (2014–2014)Michael A. Bolognese · Amgen (United States)1 papers (2014–2014) · 1 papers (2014–2014)Maria Laura Monsalvo · Amgen (United States)1 papers (2014–2014)Christie M. Ballantyne · New York University1 papers (2014–2014)Michael Lillestol · Çevre, Şehircilik ve İklim Değişikliği Bakanlığı1 papers (2014–2014)Robert C. Scott · Japan Real Estate Institute1 papers (2014–2014)Dirk Blom · South African Medical Research Council1 papers (2014–2014)Jae Bum Kim · Seoul National University1 papers (2014–2014)Scott M. Wasserman · Amgen (United States)1 papers (2014–2014)Eli M. Roth · University of Cape Town1 papers (2014–2014)Evan A. Stein · Amgen (United States)1 papers (2014–2014)